Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transgenic RPE cells overexpressing OTX2 for the treatment of retinal degeneration

Transgenic RPE cells overexpressing OTX2 for the treatment of retinal degeneration

US Patent 11865189 · Granted Jan 9, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for efficient amplification of retinal progenitors cell2025
Polymer-based implant for retinal therapy and methods of making and using the sa2025
Filter for eye cone cells protection2025
Chemical compounds targeting the eye and use thereof in the treatment of eye dis2025
Method of analyzing a visual field of an individual and a corresponding ophthalm2024
Methods of expressing a polynucleotide of interest in the cone photoreceptors of2023
Methods of expressing a polynucleotide of interest in the cone photoreceptors of2023
Mirabegron for the treatment of retinal diseases2023
Importation of mitochondrial protein by an enhanced allotopic approach2023
Neuronal viability factor and use thereof in Alzheimer's disease2022
Neuronal viability factor and use thereof in Alzheimer's disease2022
Promoters and uses thereof2022